Global Osteoporosis Therapeutics Market Growth (Status and Outlook) 2024-2030

2024

Global Osteoporosis Therapeutics Market Growth (Status and Outlook) 2024-2030

Name: Global Osteoporosis Therapeutics Market Growth (Status and Outlook) 2024-2030
SKU: 95001360
Price: 3450 USD
Availability: InStock
Rating: 5 (5 reviews)

The global pharmaceutical market, valued at USD 1,475 billion in 2022, is projected to grow at a CAGR of 5% through the next decade as demand for healthcare products rises.

Bonafide Trust
10-09-2024
Pages : 109
Figures : 79
Tables : 119
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call
Sikandar Kesari — Research Analyst

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global Osteoporosis Therapeutics market was valued at USD 10,190 million in 2024, and it is projected to grow to USD 11,900 million by 2030, registering a Compound Annual Growth Rate (CAGR) of 2.2% during the forecast period. This growth can be attributed to the rising demand for effective treatments and the growing prevalence of osteoporosis, which is a significant concern globally. Osteoporosis, often referred to as a silent disease, results in the weakening of bones, making them fragile and prone to fractures, especially in the spine, hip, and forearm. The World Health Organization (WHO) has recognized osteoporosis as a priority health issue due to its widespread impact on individuals' quality of life and the healthcare system. The increasing elderly population, along with rising awareness about bone health, is driving demand for osteoporosis therapeutics. In addition, the shift towards preventative healthcare and the growing focus on maintaining bone density as a part of overall wellness are further contributing to the market's growth. However, the widespread adoption of osteoporosis therapeutics depends on various factors such as product differentiation, reducing treatment costs, and optimizing supply chains. These challenges require pharmaceutical companies to invest heavily in research and development (R&D), build strategic partnerships, and align their offerings with the evolving needs of healthcare providers and patients. The competitive landscape is intensifying, and companies must innovate continually to address both the medical and commercial challenges of treating osteoporosis. Furthermore, market players need to focus on improving drug accessibility, ensuring that treatments are affordable and available to a broader patient population to drive long-term growth and market penetration.

According to Publisher, the global pharmaceutical market was valued at USD 1,475 billion in 2022 and is projected to grow at a CAGR of 5% during the next six years. Osteoporosis therapeutics, being a significant segment within the pharmaceutical industry, are expected to benefit from this growth. The rise in chronic diseases, the aging population, and the increasing demand for healthcare are key factors driving the demand for osteoporosis treatments. Moreover, advancements in technology, such as the development of biologics and precision medicine, are expected to further revolutionize the osteoporosis therapeutics landscape. Despite these opportunities, the market faces several challenges, such as stringent regulations, the high costs associated with drug development, and the risk of patent expirations. Pharmaceutical companies must continually adapt to these challenges, ensuring that their products meet the regulatory standards while remaining affordable and effective for patients. In particular, the increasing focus on biologic treatments, such as monoclonal antibodies and gene therapy, is driving innovation in the osteoporosis therapeutics market. Additionally, the COVID-19 pandemic highlighted the need for agile supply chains, as companies were forced to quickly adapt to new healthcare demands. Pharmaceutical companies must remain responsive to emerging public health needs and address concerns such as vaccine development and the efficient distribution of treatments. Governments and organizations worldwide are also investing in osteoporosis research and treatment, with funding for R&D expected to rise, further accelerating the development of new therapies. To stay competitive in this growing market, pharmaceutical companies will need to focus on expanding their portfolios of osteoporosis treatments while staying ahead of regulatory requirements and technological advancements. This will be essential for meeting the future needs of patients suffering from osteoporosis and ensuring the market’s continued growth.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The market is segmented by type and distribution channel, with each segment offering unique insights into consumer preferences and therapeutic trends. In terms of type, osteoporosis therapeutics include Bisphosphonates, Hormones, Strontium Ranelate, Raloxifene, Denosumab, and Others. Bisphosphonates are one of the most commonly used treatments, functioning by inhibiting bone resorption to maintain bone density and reduce fracture risks. Bisphosphonates are typically prescribed to postmenopausal women and individuals with a high risk of bone fractures. Hormonal therapies, such as estrogen and parathyroid hormone, are used to maintain bone strength and mass, especially in postmenopausal women, and they play a critical role in preventing osteoporosis-related fractures. Strontium Ranelate, a drug that has been shown to improve bone density, is used to reduce the risk of fractures in patients with osteoporosis. Raloxifene, a selective estrogen receptor modulator (SERM), is commonly prescribed to postmenopausal women to improve bone mineral density and reduce fracture risk. Denosumab, a monoclonal antibody, works by inhibiting RANKL, a protein responsible for bone resorption, thus improving bone density and reducing fracture risks. The "Others" category includes other less common treatments that may be used when standard treatments are not effective or suitable for certain patients. Each of these treatment types plays a unique role in managing osteoporosis, and the increasing number of available therapies provides healthcare providers with more options to meet individual patient needs. This diversity in treatment options is crucial for the continued growth of the osteoporosis therapeutics market, as it allows for tailored treatment regimens that address the varying needs of different patient populations.

The distribution channel segmentation of the osteoporosis therapeutics market reveals three key channels: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. Hospital pharmacies are essential for providing specialized treatments and therapies to patients with severe osteoporosis. These pharmacies offer a range of prescription medications, including biologics and other advanced therapies, and often play a critical role in the management of osteoporosis in clinical settings. Online pharmacies have become an increasingly important distribution channel, particularly with the rise of e-commerce and the growing demand for convenience among consumers. Patients can now easily access osteoporosis medications online, reducing the need for in-person visits to pharmacies. Online platforms also offer the advantage of providing a wide selection of products, often with detailed information about each treatment option, which empowers consumers to make more informed decisions about their healthcare. Retail pharmacies continue to be a significant distribution channel for over-the-counter osteoporosis treatments and medications, as they cater to patients who require easily accessible therapies. These pharmacies offer a more traditional route for obtaining medications and are often the first point of contact for consumers seeking osteoporosis treatments. Retail pharmacies are also key for maintaining consumer engagement, as patients may seek advice and support for managing their condition. The combination of these three distribution channels enables the osteoporosis therapeutics market to cater to a wide range of patient needs, from those requiring specialized treatments to those seeking convenient, accessible solutions for managing osteoporosis. Each channel plays a crucial role in ensuring the availability of treatments and contributing to the market’s overall growth.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoporosis Therapeutics Market Size 2019-2030
2.1.2 Osteoporosis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Osteoporosis Therapeutics Segment by Type
2.2.1 Bisphosphonates
2.2.2 Hormones
2.2.3 Strontium Ranelate
2.2.4 Raloxifene
2.2.5 Denosumab
2.2.6 Others
2.3 Osteoporosis Therapeutics Market Size by Type
2.3.1 Osteoporosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Osteoporosis Therapeutics Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Osteoporosis Therapeutics Market Size by Distribution Channel
2.5.1 Osteoporosis Therapeutics Market Size CAGR by Distribution Channel (2019 VS 2023 VS 2030)
2.5.2 Global Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
3 Osteoporosis Therapeutics Market Size by Player
3.1 Osteoporosis Therapeutics Market Size Market Share by Players
3.1.1 Global Osteoporosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Osteoporosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Osteoporosis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Osteoporosis Therapeutics by Regions
4.1 Osteoporosis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Osteoporosis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Osteoporosis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Osteoporosis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Osteoporosis Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Osteoporosis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Osteoporosis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osteoporosis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Osteoporosis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Osteoporosis Therapeutics by Country (2019-2024)
7.2 Europe Osteoporosis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Osteoporosis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Osteoporosis Therapeutics Market Forecast
10.1 Global Osteoporosis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Osteoporosis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Osteoporosis Therapeutics Forecast
10.1.3 APAC Osteoporosis Therapeutics Forecast
10.1.4 Europe Osteoporosis Therapeutics Forecast
10.1.5 Middle East & Africa Osteoporosis Therapeutics Forecast
10.2 Americas Osteoporosis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Osteoporosis Therapeutics Market Forecast
10.2.2 Canada Osteoporosis Therapeutics Market Forecast
10.2.3 Mexico Osteoporosis Therapeutics Market Forecast
10.2.4 Brazil Osteoporosis Therapeutics Market Forecast
10.3 APAC Osteoporosis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Osteoporosis Therapeutics Market Forecast
10.3.2 Japan Osteoporosis Therapeutics Market Forecast
10.3.3 Korea Osteoporosis Therapeutics Market Forecast
10.3.4 Southeast Asia Osteoporosis Therapeutics Market Forecast
10.3.5 India Osteoporosis Therapeutics Market Forecast
10.3.6 Australia Osteoporosis Therapeutics Market Forecast
10.4 Europe Osteoporosis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Osteoporosis Therapeutics Market Forecast
10.4.2 France Osteoporosis Therapeutics Market Forecast
10.4.3 UK Osteoporosis Therapeutics Market Forecast
10.4.4 Italy Osteoporosis Therapeutics Market Forecast
10.4.5 Russia Osteoporosis Therapeutics Market Forecast
10.5 Middle East & Africa Osteoporosis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Osteoporosis Therapeutics Market Forecast
10.5.2 South Africa Osteoporosis Therapeutics Market Forecast
10.5.3 Israel Osteoporosis Therapeutics Market Forecast
10.5.4 Turkey Osteoporosis Therapeutics Market Forecast
10.5.5 GCC Countries Osteoporosis Therapeutics Market Forecast
10.6 Global Osteoporosis Therapeutics Forecast by Type (2025-2030)
10.7 Global Osteoporosis Therapeutics Forecast by Distribution Channel (2025-2030)
11 Key Players Analysis
11.1 Warner Chilcott
11.1.1 Warner Chilcott Company Information
11.1.2 Warner Chilcott Osteoporosis Therapeutics Product Offered
11.1.3 Warner Chilcott Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Warner Chilcott Main Business Overview
11.1.5 Warner Chilcott Latest Developments
11.2 Merck & Co.
11.2.1 Merck & Co. Company Information
11.2.2 Merck & Co. Osteoporosis Therapeutics Product Offered
11.2.3 Merck & Co. Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co. Main Business Overview
11.2.5 Merck & Co. Latest Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Osteoporosis Therapeutics Product Offered
11.3.3 Roche Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Main Business Overview
11.3.5 Roche Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Osteoporosis Therapeutics Product Offered
11.4.3 Novartis Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Ono
11.5.1 Ono Company Information
11.5.2 Ono Osteoporosis Therapeutics Product Offered
11.5.3 Ono Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Ono Main Business Overview
11.5.5 Ono Latest Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Information
11.6.2 Astellas Pharma Osteoporosis Therapeutics Product Offered
11.6.3 Astellas Pharma Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Astellas Pharma Main Business Overview
11.6.5 Astellas Pharma Latest Developments
11.7 Procter & Gamble
11.7.1 Procter & Gamble Company Information
11.7.2 Procter & Gamble Osteoporosis Therapeutics Product Offered
11.7.3 Procter & Gamble Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Procter & Gamble Main Business Overview
11.7.5 Procter & Gamble Latest Developments
11.8 Sumitomo Pharmaceuticals
11.8.1 Sumitomo Pharmaceuticals Company Information
11.8.2 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Product Offered
11.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sumitomo Pharmaceuticals Main Business Overview
11.8.5 Sumitomo Pharmaceuticals Latest Developments
11.9 Servier
11.9.1 Servier Company Information
11.9.2 Servier Osteoporosis Therapeutics Product Offered
11.9.3 Servier Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Servier Main Business Overview
11.9.5 Servier Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Osteoporosis Therapeutics Product Offered
11.10.3 Eli Lilly Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Osteoporosis Therapeutics Product Offered
11.11.3 Pfizer Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Osteoporosis Therapeutics Product Offered
11.12.3 Amgen Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Amgen Main Business Overview
11.12.5 Amgen Latest Developments
11.13 Chugai
11.13.1 Chugai Company Information
11.13.2 Chugai Osteoporosis Therapeutics Product Offered
11.13.3 Chugai Osteoporosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Chugai Main Business Overview
11.13.5 Chugai Latest Developments
12 Research Findings and Conclusion

Table 1. Osteoporosis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Bisphosphonates
Table 3. Major Players of Hormones
Table 4. Major Players of Strontium Ranelate
Table 5. Major Players of Raloxifene
Table 6. Major Players of Denosumab
Table 7. Major Players of Others
Table 8. Osteoporosis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Osteoporosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 11. Osteoporosis Therapeutics Market Size CAGR by Distribution Channel (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 13. Global Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Table 14. Global Osteoporosis Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Osteoporosis Therapeutics Revenue Market Share by Player (2019-2024)
Table 16. Osteoporosis Therapeutics Key Players Head office and Products Offered
Table 17. Osteoporosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Osteoporosis Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Osteoporosis Therapeutics Market Size Market Share by Regions (2019-2024)
Table 22. Global Osteoporosis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Osteoporosis Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Osteoporosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Osteoporosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 26. Americas Osteoporosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 28. Americas Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 29. Americas Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Table 30. APAC Osteoporosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Osteoporosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 32. APAC Osteoporosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 34. APAC Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 35. APAC Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Table 36. Europe Osteoporosis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Osteoporosis Therapeutics Market Size Market Share by Country (2019-2024)
Table 38. Europe Osteoporosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 40. Europe Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 41. Europe Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Table 42. Middle East & Africa Osteoporosis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Osteoporosis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Osteoporosis Therapeutics Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Osteoporosis Therapeutics
Table 49. Key Market Challenges & Risks of Osteoporosis Therapeutics
Table 50. Key Industry Trends of Osteoporosis Therapeutics
Table 51. Global Osteoporosis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Osteoporosis Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Osteoporosis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Osteoporosis Therapeutics Market Size Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 55. Warner Chilcott Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 56. Warner Chilcott Osteoporosis Therapeutics Product Offered
Table 57. Warner Chilcott Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Warner Chilcott Main Business
Table 59. Warner Chilcott Latest Developments
Table 60. Merck & Co. Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 61. Merck & Co. Osteoporosis Therapeutics Product Offered
Table 62. Merck & Co. Main Business
Table 63. Merck & Co. Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Merck & Co. Latest Developments
Table 65. Roche Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 66. Roche Osteoporosis Therapeutics Product Offered
Table 67. Roche Main Business
Table 68. Roche Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Roche Latest Developments
Table 70. Novartis Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 71. Novartis Osteoporosis Therapeutics Product Offered
Table 72. Novartis Main Business
Table 73. Novartis Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Novartis Latest Developments
Table 75. Ono Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 76. Ono Osteoporosis Therapeutics Product Offered
Table 77. Ono Main Business
Table 78. Ono Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Ono Latest Developments
Table 80. Astellas Pharma Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 81. Astellas Pharma Osteoporosis Therapeutics Product Offered
Table 82. Astellas Pharma Main Business
Table 83. Astellas Pharma Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Astellas Pharma Latest Developments
Table 85. Procter & Gamble Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 86. Procter & Gamble Osteoporosis Therapeutics Product Offered
Table 87. Procter & Gamble Main Business
Table 88. Procter & Gamble Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Procter & Gamble Latest Developments
Table 90. Sumitomo Pharmaceuticals Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 91. Sumitomo Pharmaceuticals Osteoporosis Therapeutics Product Offered
Table 92. Sumitomo Pharmaceuticals Main Business
Table 93. Sumitomo Pharmaceuticals Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Sumitomo Pharmaceuticals Latest Developments
Table 95. Servier Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 96. Servier Osteoporosis Therapeutics Product Offered
Table 97. Servier Main Business
Table 98. Servier Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Servier Latest Developments
Table 100. Eli Lilly Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 101. Eli Lilly Osteoporosis Therapeutics Product Offered
Table 102. Eli Lilly Main Business
Table 103. Eli Lilly Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Eli Lilly Latest Developments
Table 105. Pfizer Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 106. Pfizer Osteoporosis Therapeutics Product Offered
Table 107. Pfizer Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Amgen Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 111. Amgen Osteoporosis Therapeutics Product Offered
Table 112. Amgen Main Business
Table 113. Amgen Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Amgen Latest Developments
Table 115. Chugai Details, Company Type, Osteoporosis Therapeutics Area Served and Its Competitors
Table 116. Chugai Osteoporosis Therapeutics Product Offered
Table 117. Chugai Main Business
Table 118. Chugai Osteoporosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Chugai Latest Developments
List of

Figure 1. Osteoporosis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Osteoporosis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Osteoporosis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Osteoporosis Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Osteoporosis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Osteoporosis Therapeutics Market Size Market Share by Type in 2023
Figure 10. Osteoporosis Therapeutics in Hospital Pharmacies
Figure 11. Global Osteoporosis Therapeutics Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Osteoporosis Therapeutics in Online Pharmacies
Figure 13. Global Osteoporosis Therapeutics Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 14. Osteoporosis Therapeutics in Retail Pharmacies
Figure 15. Global Osteoporosis Therapeutics Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Osteoporosis Therapeutics Market Size Market Share by Distribution Channel in 2023
Figure 17. Global Osteoporosis Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Osteoporosis Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Osteoporosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Osteoporosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Osteoporosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Osteoporosis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Osteoporosis Therapeutics Value Market Share by Country in 2023
Figure 24. United States Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Osteoporosis Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Osteoporosis Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Osteoporosis Therapeutics Market Size Market Share by Distribution Channel in 2023
Figure 31. China Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Osteoporosis Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Figure 40. Germany Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Osteoporosis Therapeutics Market Size Market Share by Distribution Channel (2019-2024)
Figure 48. Egypt Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Osteoporosis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Osteoporosis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Osteoporosis Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Osteoporosis Therapeutics Market Size Market Share Forecast by Distribution Channel (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted